The High Court's recent judgement in Generics (UK) Limited v Astrazeneca AB (EWHC 2203 (Pat)) has established important precedents regarding cost allocation in multi-party patent disputes. Deputy ...
CHENNAI: India's pharmaceutical exports reached US$30.5 billion in FY2025, marking a 9.3% increase from the previous year, according to a new report by Rubix Data Sciences, a leading provider of risk ...
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening the door to cheaper generic copycats, after the drug giant reportedly ...
The United States Food and Drug Administration (USFDA) (Image Credits: Reuters) The United States Food and Drug Administration (USFDA) has approved the first generics of Xarelto (rivaroxaban) tablets ...
Danish drugmaker Novo Nordisk is prepared to enter the Indian market and other markets with its blockbuster drug Ozempic, despite losing patent exclusivity early next year. “Even as we face patent ...
WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug Entresto ...
Indian pharma companies have long been key providers of generic medicines to the US market, accounting for 47% of all generic prescriptions in 2022, according to a recent report by the IQVIA Institute ...
NATCO Pharma Ltd on Monday announced that its partner Mylan Pharmaceuticals Inc has reached a patent litigation settlement with Novo Nordisk in the US over generic Ozempic, a drug used to lower blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback